Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
Stewart J TepperMessoud AshinaUwe ReuterJan Lewis BrandesDavid DoležilStephen D SilbersteinPaul WinnerFeng ZhangSunfa ChengDaniel D MikolPublished in: Cephalalgia : an international journal of headache (2020)
This study is registered at ClinicalTrials.gov (NCT02174861).